Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury

被引:208
作者
Khanna, S
Davis, D
Peterson, B
Fisher, B
Tung, H
O'Quigley, J
Deutsch, R
机构
[1] Univ Calif San Diego, Childrens Hosp, Div Pediat Crit Care Med, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Gen Clin Res Ctr, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA
关键词
hypertonic saline; sodium; osmolarity; creatinine; intracranial pressure; cerebral perfusion pressure; Glasgow Coma Scale score; Glasgow Outcome Scale score; computed tomography; head injury;
D O I
10.1097/00003246-200004000-00038
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To evaluate the effect of prolonged infusion of 3% hypertonic saline (514 mEq/L) and sustained hypernatremia on refractory intracranial hypertension in pediatric traumatic brain injury patients. Design: A prospective study. Setting: a 24-bed Pediatric Intensive Care Unit (Level III) at Children's Hospital. Patients: We present ten children with increased intracranial pressure (ICP) resistant to conventional therapy (head elevation at 30 degrees, normothermia, sedation, paralysis and analgesia, osmolar therapy with mannitol, loop diuretic, external vertricular drainage in five patients), controlled hyperventilation (PCO2, 28-35 mm Hg), and barbiturate coma. We continuously monitored ICP, cerebral perfusion pressure (CPP), mean arterial pressure, central venous pressure, serum sodium concentrations, serum osmolarity, and serum creatinine. Interventions: A continuous infusion of 3% saline on a sliding scale was used to achieve a target serum sodium level that would maintain ICP <20 mm Hg once the conventional therapy and barbiturate coma as outlined above failed to control intracranial hypertension. Measurements and Main Results: The mean duration of treatment with 3% saline was 7.6 days (range, 4-18 days). The mean highest serum sodium was 170.7 mEq/L (range, 157-187 mEq/L). The mean highest serum osmolarity was 364.8 mosm/L (range, 330-431 mosm/L). The mean highest serum creatinine was 1.31 mg/dL (range, 0.4-5.0 mg/dL). There was a steady increase in serum sodium versus time zero that reached statistical significance at 24, 48, and 72 hrs (p < .01). There was a statistically significant decrease in ICP spike frequency at 6, 12, 24, 48, and 72 hrs (p < .01). There was a statistically significant increase in CPP versus time zero at 6, 12, 24, 48, and 72 hrs (p < .01). There was a statistically significant increase in serum osmolarity versus time zero at 12 hrs (p < .05) and at 24, 48, and 72 hrs (p < .01). Two patients developed acute renal failure and required continuous veno-venous hemodialysis; these were concurrent with an episode of sepsis and multisystem organ dysfunction. Both recovered full renal function with no electrolyte abnormalities at the time of discharge. Conclusion: An increase in serum sodium concentration significantly decreases ICP and increases CPP. Hypertonic saline is an effective agent to increase serum sodium concentrations. Sustained hypernatremia and hyperosmolarity are safely tolerated in pediatric patients with traumatic brain injury. Controlled trials are needed before recommendation of widespread use.
引用
收藏
页码:1144 / 1151
页数:8
相关论文
共 50 条
  • [31] Higher-volume hypertonic saline and increased thrombotic risk in pediatric traumatic brain injury
    Webster, Danielle L.
    Fei, Lin
    Falcone, Richard A.
    Kaplan, JenniferM.
    [J]. JOURNAL OF CRITICAL CARE, 2015, 30 (06) : 1267 - 1271
  • [32] Hypertonic saline for the treatment of intracranial hypertension: Worth its salt
    Levine, Joshua M.
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (12) : 3037 - 3039
  • [33] Brain metabolism and severe pediatric traumatic brain injury
    Griffiths, Heidi
    Goyal, Manu S.
    Pineda, Jose A.
    [J]. CHILDS NERVOUS SYSTEM, 2017, 33 (10) : 1719 - 1726
  • [34] Intracranial pressure-based barbiturate coma treatment in children with refractory intracranial hypertension due to traumatic brain injury
    Velle, Fartein
    Lewen, Anders
    Howells, Timothy
    Enblad, Per
    Nilsson, Pelle
    [J]. JOURNAL OF NEUROSURGERY-PEDIATRICS, 2020, 25 (04) : 375 - 383
  • [35] Use of hypertonic (3%)saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain
    Qureshi, AI
    Suarez, JI
    Bhardwaj, A
    Mirski, M
    Schnitzer, MS
    Hanley, DF
    Ulatowski, JA
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (03) : 440 - 446
  • [36] Corticosteroid treatment for refractory intracranial hypertension: a rescue therapy in patients with severe traumatic brain injury with contusional lesions—a feedback
    Sophie Menat
    Alice Jacquens
    Bertrand Mathon
    Baptiste Bonnet
    Eimad Schotar
    Anne-Laure Boch
    Alexandre Carpentier
    Louis Puybasset
    Lamine Abdennour
    Vincent Degos
    [J]. Acta Neurochirurgica, 2023, 165 : 717 - 725
  • [37] Hypertonic saline infusion in traumatic brain injury increases the incidence of pulmonary infection
    Coritsidis, George
    Diamond, Nechama
    Rahman, Aleef
    Solodnik, Paul
    Lawrence, Kayode
    Rhazouani, Salwa
    Phalakornkul, Suganda
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (08) : 1332 - 1337
  • [38] Timing of Intracranial Hypertension Following Severe Traumatic Brain Injury
    Deborah M. Stein
    Megan Brenner
    Peter F. Hu
    Shiming Yang
    Erin C. Hall
    Lynn G. Stansbury
    Jay Menaker
    Thomas M. Scalea
    [J]. Neurocritical Care, 2013, 18 : 332 - 340
  • [39] Intracranial hypertension and outcome following severe traumatic brain injury
    Magnoni, S.
    Stocchetti, N.
    [J]. MINERVA ANESTESIOLOGICA, 2014, 80 (12) : 1251 - 1252
  • [40] Fentanyl and Midazolam Are Ineffective in Reducing Episodic Intracranial Hypertension in Severe Pediatric Traumatic Brain Injury
    Welch, Timothy P.
    Wallendorf, Michael J.
    Kharasch, Evan D.
    Leonard, Jeffrey R.
    Doctor, Allan
    Pineda, Jose A.
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (04) : 809 - 818